The role of fetuin-A in physiological and pathological mineralization

Calcified Tissue International

Volumn 93, Issue 4, 2013, Pages 355-364

  Brylka, Laura ^a   Jahnen Dechent, Willi ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Chondrocyte; Ectopic calcification; Fetuin A; Matrix protein; Osteoblast

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; CELL PROTEIN; COLLAGEN TYPE 1; FETUIN A; LIPID; MATRIX GLA PROTEIN; PHOSPHATE; STEROID HORMONE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE DEVELOPMENT; BONE GROWTH; BONE MATRIX; BONE MINERALIZATION; BONE STRUCTURE; CALCIUM BINDING; CARTILAGE CELL; CARTILAGE MINERALIZATION; CHEMICAL INTERACTION; CORTICAL BONE; CRYSTALLIZATION; DEVELOPMENTAL DISORDER; DISEASE ACTIVITY; DISEASE COURSE; ENCHONDRAL OSSIFICATION; EXTRACELLULAR MATRIX; GROWTH PLATE; GROWTH REGULATION; HUMAN; LONG BONE; MINERALIZATION; NONHUMAN; OSTEOBLAST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOFT TISSUE CALCIFICATION;

ALPHA-2-HS-GLYCOPROTEIN; ANIMALS; APOPTOSIS; BLOOD PROTEINS; BONE AND BONES; BONE DEVELOPMENT; CALCIFICATION, PHYSIOLOGIC; CALCINOSIS; CALCIUM PHOSPHATES; CHONDROCYTES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; HUMANS; LIPIDS; MICE; MICE, TRANSGENIC; OSTEOBLASTS; PROTEIN BINDING;

EID: 84886090843     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-012-9690-6     Document Type: Article

References (70)

1. Neuman MW (1982) Blood:bone equilibrium. Calcif Tissue Int 34:117-120 (Pubitemid 12128637)
2. Neuman WF (1980) Bone material and calcification mechanisms. In: Urist M (ed) Fundamental and clinical bone physiology. Lippincott Williams and Wilkins, Philadelphia, pp 83-107
3. Pedersen K (1944) Fetuin, a new globulin isolated from serum. Nature 154:575
4. Schäfer C, Jahnen-Dechent W, Brandenburg V (2005) Klinische relevanz des serumproteins fetuin-A - Einem regulator der kalzifizierung. Laborwelt 6:9-12
5. Nie Z (1992) Fetuin: its enigmatic property of growth promotion. Am J Physiol 263:551-562
6. Termine JD (1988) Non-collagen proteins in bone. Ciba Found Symp 136:178-202
7. Dickson IR, Poole AR, Veis A (1975) Localisation of plasma alpha2HS glycoprotein in mineralising human bone. Nature 256:430-432
8. Triffitt JT, Owen ME, Ashton BA, Wilson JM (1978) Plasma disappearance of rabbit alpha2HS-glycoprotein and its uptake by bone tissue. Calcif Tissue Res 26:155-161
9. Schultze HE, Heide K, Haupt H (1962) Charakterisierung eines niedermolekularen A2-mukoids aus humanserum. Naturwissenschaften 49:15-17
10. Heremans J (1960) Les globulines sériques du système gamma. Arscia, Brussels
11. Bürgi W, Schmid K (1961) Preparation and properties of Zn-alpha 2-glycoprotein of normal human plasma. J Biol Chem 236:1066-1074
12. Olivier E, Soury E, Ruminy P, Husson A, Parmentier F, Daveau M, Salier J (2000) Fetuin-B, a second member of the fetuin family in mammals. Biochem J 350:589-597
13. Lee C, Bongcam-Rudloff E, Söllner C, Jahnen-Dechent W, Claesson-Welsh L (2009) Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein. Front Biosci 14:2911-2922
14. Kellermann J, Haupt H, Auerswald E, Müller-Esterl W (1989) The arrangement of disulfide loops in human alpha 2-HS glycoprotein: similarity to the disulfide bridge structures of cystatins and kininogens. J Biol Chem 264:14121-14128 (Pubitemid 19214240)
15. Yamamoto K, Sinohara H (1993) Isolation and characterization of mouse countertrypsin, a new trypsin inhibitor belonging to the mammalian fetuin family. J Biol Chem 268:17750-17753 (Pubitemid 23260282)
16. Heiss A, DuChesne A, Denecke B, Grötzinger J, Yamamoto K, Renné T, Jahnen-Dechent W (2003) Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A: formation of colloidal calciprotein particles. J Biol Chem 278:13333-13341 (Pubitemid 36800105)
17. Schäfer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Müller-Esterl W, Schinke T, Jahnen-Dechent W (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357-366 (Pubitemid 38063764)
18. Jahnen-Dechent W, Heiss A, Schäfer C, Ketteler M (2011) Fetuin-A regulation of calcified matrix metabolism. Circ Res 108:1494-1509
19. Wessling J (2007) Gene deletion and functional analysis of fetuin-B. Dissertation RWTH, Aachen
20. Li W, Zhu S, Li J, Huang Y, Zhou R, Fan X, Yang H, Gong X, Eissa NT, Jahnen-Dechent W, Wang P, Tracey KJ, Sama AE, Wang H (2011) A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation. PLoS ONE 6:e16945
21. Kumbla L, Cayatte AJ, Subbiah MT (1989) Association of a lipoprotein-like particle with bovine fetuin. FASEB J 3:2075-2080 (Pubitemid 19187617)
22. Cayatte AJ, Kumbla L, Subbiah MT (1990) Marked acceleration of exogenous fatty acid incorporation into cellular triglycerides by fetuin. J Biol Chem 265:5883-5888
23. Kumbla L, Bhadra S, Subbiah MT (1991) Multifunctional role for fetuin (fetal protein) in lipid transport. FASEB J 5:2971-2975 (Pubitemid 21905839)
24. Demetriou M, Binkert C, Sukhu B, Tenenbaum H, Dennis J (1996) Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J Biol Chem 271:12755-12761 (Pubitemid 26175845)
25. Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473:317-325
26. Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, Ray S, Majumdar SS, Bhattacharya S (2012) Fetuin-A acts as an endogenous ligand of Tlr4 to promote lipid-induced insulin resistance. Nat Med 18:1279-1285
27. Seto J, Busse B, Gupta HS, Schäfer C, Krauss S, Dunlop JWC, Masic A, Kerschnitzki M, Zaslansky P, Boesecke P, Catala-Lehnen P, Schinke T, Fratzl P, Jahnen-Dechent W (2012) Accelerated growth plate mineralization and foreshortened proximal limb bones in fetuin-A knockout mice. PLoS ONE 7:e47338
28. Golub EE (2011) Biomineralization and matrix vesicles in biology and pathology. Semin Immunopathol 33:409-417
29. Boonrungsiman S, Gentleman E, Carzaniga R, Evans ND, McComb DW, Porter AE, Stevens MM (2012) The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formation. Proc Natl Acad Sci USA 109:14170-14175
30. Mahamid J, Aichmayer B, Shimoni E, Ziblat R, Li C, Siegel S, Paris O, Fratzl P, Weiner S, Addadi L (2010) Mapping amorphous calcium phosphate transformation into crystalline mineral from the cell to the bone in zebrafish fin rays. Proc Natl Acad Sci USA 107:6316-6321
31. Nudelman F, Pieterse K, George A, Bomans PHH, Friedrich H, Brylka LJ, Hilbers PAJ, de With G, Sommerdijk NAJM (2010) The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors. Nat Mater 9:1004-1009
32. McNally EA, Schwarcz HP, Botton GA, Arsenault AL (2012) A model for the ultrastructure of bone based on electron microscopy of ion-milled sections. PLoS ONE 7:e29258
33. Kinney JH, Pople JA, Driessen CH, Breunig TM, Marshall GW, Marshall SJ (2001) Intrafibrillar mineral may be absent in dentinogenesis imperfecta type II (Di-II). J Dent Res 80:1555-1559
34. Hart PS, Hart TC (2007) Disorders of human dentin. Cells Tissues Organs 186:70-77 (Pubitemid 47026718)
35. Kinney JH, Habelitz S, Marshall SJ, Marshall GW (2003) The importance of intrafibrillar mineralization of collagen on the mechanical properties of dentin. J Dent Res 82:957-961 (Pubitemid 41713811)
36. Keeley FW, Sitarz EE (1985) Identification and quantitation of alpha 2-HS-glycoprotein in the mineralized matrix of calcified plaques of atherosclerotic human aorta. Atherosclerosis 55:63-69 (Pubitemid 15064939)
37. Moe SM, Reslerova M, Ketteler M, O'Neill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX (2005) Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67:2295-2304 (Pubitemid 41623389)
38. Emoto M, Mori K, Lee E, Kawano N, Yamazaki Y, Tsuchikura S, Morioka T, Koyama H, Shoji T, Inaba M, Nishizawa Y (2010) Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus. Metabolism 59:873-878
39. Schinke T, Amendt C, Trindl A, Pöschke O, Müller-Esterl W, Jahnen-Dechent W (1996) The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells: a possible role in mineralization and calcium homeostasis. J Biol Chem 271:20789-20796 (Pubitemid 26281865)
40. Toroian D, Price PA (2007) The essential role of fetuin in the serum-induced calcification of collagen. Calcif Tissue Int 82:116-126
41. Zmuda JM, Eichner JE, Ferrell RE, Bauer DC, Kuller LH, Cauley JA (1998) Genetic variation in alpha 2HS-glycoprotein is related to calcaneal broadband ultrasound attenuation in older women. Calcif Tissue Int 63:5-8 (Pubitemid 28289927)
42. Price PA, Toroian D, Lim JE (2009) Mineralization by inhibitor exclusion: the calcification of collagen with fetuin. J Biol Chem 284:17092-17101
43. Toroian D, Lim JE, Price PA (2007) The size exclusion characteristics of type i collagen: implications for the role of noncollagenous bone constituents in mineralization. J Biol Chem 282:22437-22447 (Pubitemid 47267338)
44. Szweras M, Liu D, Partridge EA, Pawling J, Sukhu B, Clokie C, Jahnen-Dechent W, Tenenbaum HC, Swallow CJ, Grynpas MD, Dennis JW (2002) Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 277:19991-19997 (Pubitemid 34967522)
45. Li T-F, O'Keefe RJ, Chen D (2005) TGF-beta signaling in chondrocytes. Front Biosci 10:681-688
46. Shu B, Zhang M, Xie R, Wang M, Jin H, Hou W, Tang D, Harris SE, Mishina Y, O'Keefe RJ, Hilton MJ, Wang Y, Chen D (2011) Bmp2, but not Bmp4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. J Cell Sci 124:3428-3440
47. Merx MW, Schäfer C, Westenfeld R, Brandenburg V, Hidajat S, Weber C, Ketteler M, Jahnen-Dechent W (2005) Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. J Am Soc Nephrol 16:3357-3364 (Pubitemid 46179339)
48. Westenfeld R, Schäfer C, Smeets R, Brandenburg VM, Floege J, Ketteler M, Jahnen-Dechent W (2007) Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant 22:1537-1546 (Pubitemid 47073751)
49. Jahnen-Dechent W, Schäfer C, Ketteler M, McKee MD (2008) Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 86:379-389
50. Luo G, Ducy P, McKee M, Pinero G, Loyer E, Behringer R, Karsenty G (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature 386:78-81 (Pubitemid 27130923)
51. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857-2867 (Pubitemid 41103395)
52. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, Jahnen-Dechent W, Shanahan CM (2005) Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16:2920-2930 (Pubitemid 44743490)
53. Ghadially F (2001) As you like it, part 3: a critique and historical review of calcification as seen with the electron microscope. Ultrastruct Pathol 25:243-267 (Pubitemid 32607297)
54. Heiss A, Pipich V, Jahnen-Dechent W, Schwahn D (2010) Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on fetuin-A controlled calcification inhibition. Biophys J 99:3986-3995
55. Rochette CN, Rosenfeldt S, Heiss A, Narayanan T, Ballauff M, Jahnen-Dechent W (2009) A shielding topology stabilizes the early stage protein-mineral complexes of fetuin-A and calcium phosphate: a time-resolved small-angle X-ray study. ChemBioChem 10:735-740
56. Wald J, Wiese S, Eckert T, Jahnen-Dechent W, Richtering W, Heiss A (2011) Formation and stability kinetics of calcium phosphate-fetuin-A colloidal particles probed by time-resolved dynamic light scattering. Soft Matter 7:2869-2874
57. Heiss A, Jahnen-Dechent W, Endo H, Schwahn D (2007) Structural dynamics of a colloidal protein-mineral complex bestowing on calcium phosphate a high solubility in biological fluids. Biointerphases 2:16-20
58. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827-833 (Pubitemid 36331846)
59. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimbürger O, Holmes C, Schalling M, Nordfors L (2005) Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 67:2383-2392 (Pubitemid 41623401)
60. Herrmann M, Kinkeldey A, Jahnen-Dechent W (2012) Fetuin-A function in systemic mineral metabolism. Trends Cardiovasc Med 22:197-201
61. Herrmann M, Schäfer C, Heiss A, Gräber S, Kinkeldey A, Büscher A, Schmitt MMN, Bornemann J, Nimmerjahn F, Herrmann M, Helming L, Gordon S, Jahnen-Dechent W (2012) Clearance of fetuin-A-containing calciprotein particles is mediated by scavenger receptor-A. Circ Res 111:575-584
62. Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333-337 (Pubitemid 9110191)
63. Pasch A, Farese S, Gräber S, Wald J, Richtering W, Floege J, Jahnen-Dechent W (2012) A nanoparticle-based serum test measuring overall calcification inhibition. J Am Soc Nephrol 23:1744-1752
64. London GM (2009) Bone-vascular axis in chronic kidney disease: a reality? Clin J Am Soc Nephrol 4:254-257
65. Osako MK, Nakagami H, Koibuchi N, Shimizu H, Nakagami F, Koriyama H, Shimamura M, Miyake T, Rakugi H, Morishita R (2010) Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ Res 107:466-475
66. Ketteler M, Schlieper G, Floege J (2006) Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 47:1027-1034 (Pubitemid 44289155)
67. Weenig RH (2008) Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol 58:458-471
68. Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989-2003
69. Demetriou ETW, Pietras SM, Holick MF (2010) Hypercalcemia and soft tissue calcification owing to sarcoidosis: the sunlight-cola connection. J Bone Miner Res 25:1695-1699
70. Kaklamanos M, Perros P (2007) Milk alkali syndrome without the milk. BMJ 335:397-398 (Pubitemid 47359320)